A carregar...
Efficiency and Safety of Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody on Hypercholesterolemia: A Meta-Analysis of 20 Randomized Controlled Trials
BACKGROUND: Proprotein convertase subtilisin/kexin9 (PCSK9) monoclonal antibody significantly reduces low-density lipoprotein cholesterol level in patients with hypercholesterolemia. The goal of this study was to review recently reported randomized controlled trials to investigate the therapeutic ef...
Na minha lista:
| Publicado no: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599534/ https://ncbi.nlm.nih.gov/pubmed/26077586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.001937 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|